Welcome to our dedicated page for Senestech news (Ticker: SNES), a resource for investors and traders seeking the latest updates and insights on Senestech stock.
SenesTech Inc (SNES) provides innovative fertility control solutions for sustainable rodent management through its EPA-registered products. This news hub offers investors and pest control professionals timely updates on corporate developments and scientific advancements in humane pest control technology.
Access official press releases covering product launches, regulatory milestones, and partnership announcements. Our curated collection includes updates on ContraPest deployments, Evolve soft bait applications, and research breakthroughs in integrated pest management strategies.
Discover updates organized by key operational areas: regulatory approvals, distribution expansions, and scientific validation studies. Stay informed about developments in non-lethal pest control solutions that align with global sustainability initiatives and changing environmental regulations.
Bookmark this page for direct access to SenesTech's verified announcements. Monitor progress in biotechnology applications for urban pest management and ecological preservation through our comprehensive news repository.
SenesTech (NASDAQ: SNES) announced on Nov 11, 2025 that the Belize Raptor Center, led by Sarah Mann, is an official international distributor of Evolve Rat Birth Control after receiving import and distribution approval from the Pesticides Control Board of Belize. The move aims to offer a non‑lethal, fertility‑based alternative to toxic rodenticides to protect Belize's biodiversity and reduce secondary wildlife poisonings.
The distributor partnership includes a grassroots education campaign for citizens, businesses, and officials to promote integrated pest management and phase out harmful anticoagulant and neurotoxic rodenticides.
SenesTech (NASDAQ: SNES) reported Q3 2025 results with record revenue of $690,000, a 43% increase versus Q3 2024, driven by 77% YoY growth in Evolve Rodent Birth Control products, which now represent 85% of total revenue. Gross margin was 62.8%. Net loss narrowed to $1.3M from $1.5M, and Adjusted EBITDA loss improved to $1.2M, both company records. Cash and short-term investments totaled $10.2M, supporting the company's runway and pursuit of breakeven. Key channel growth: e-commerce +55% YoY, municipal +139% YoY, retail +254% YoY, and pest management +29% YoY (≈20% of revenue).
The company highlighted multi-channel distribution traction, one-time Q3 legal and lease costs, and a webcast conference call on Nov 10, 2025.
SenesTech (NASDAQ: SNES) announced that its Evolve® Rat Birth Control® is now available online at Lowes.com as of Nov. 10, 2025. This e-commerce launch gives Evolve Rat access to millions of homeowners via one of the nation's largest home improvement retailers.
Company notes Lowes has over 1,700 stores and $11 billion in online sales, growing at nearly 10% per year. The product is described as a non‑poison, soft bait that reduces rat reproduction and is positioned for potential in‑store expansion if online demand supports retail rollout.
SenesTech (NASDAQ: SNES) will report third quarter 2025 financial results for the period ended September 30, 2025 after the market close on Monday, November 10, 2025.
The company will host a conference call the same day at 5:00 p.m. Eastern time to review results. Interested parties can access the live webcast via the Investor Relations section of the company website at https://app.webinar.net/Pj7rLgb3Ew4 or http://senestech.investorroom.com/. A webcast replay will be available on the Investor Relations site for 90 days.
SenesTech (NASDAQ: SNES) announced the Town of Swampscott launched a pilot deploying Evolve® Rat Birth Control at the Swampscott Firehouse and a local school beginning Oct. 13, 2025.
The humane fertility control bait targets rat reproduction rather than using traditional poisons and is described as palatable to rats and safe for non-target species. The pilot runs through the fall with monitoring by city officials, product specialists, Speak Up for Animals, and local advocates; expansion to more neighborhoods in 2026 is possible if results are successful.
SenesTech (NASDAQ: SNES), a leader in fertility control solutions for animal pest populations, has announced its participation in the upcoming Lytham Partners Fall 2025 Investor Conference on September 30, 2025.
The company will deliver a webcast presentation at 2:45 p.m. ET and conduct one-on-one meetings with investors during the virtual event. Investors can access the webcast through the conference website and schedule individual meetings with management through Lytham Partners.
SenesTech (NASDAQ: SNES) announced that its Evolve™ Rat Birth Control product is now available for purchase on HomeDepot.com, marking a significant expansion in consumer accessibility. The product is the first and only soft bait targeting rat reproduction, offering a non-toxic alternative to traditional pest control methods.
The launch on Home Depot's online platform, which processed over 395 million online transactions in 2024, represents a strategic move to reach millions of homeowners through a major retail channel. The product can be shipped nationwide for store pickup or direct delivery to consumers.
SenesTech (NASDAQ: SNES) announced the expansion of its Evolve™ Rat Birth Control solution to Chicago's Old Town Special Service Area #48. The deployment will cover strategic alleyways throughout the SSA, which spans approximately 0.6 square miles and supports over 200 businesses.
The initiative, led by the Old Town Merchants and Residents Association (OTMRA), aims to address rodent control in a sustainable way. Evolve™, classified as a minimum-risk pesticide by the EPA, is designed to reduce fertility in both male and female rats without harming non-target animals, making it ideal for urban environments.
SenesTech (NASDAQ: SNES), a company specializing in fertility control solutions for animal pest populations, has announced its participation in the upcoming Lytham Partners 2025 Consumer & Technology Investor Summit. The virtual presentation is scheduled for Tuesday, August 19, 2025, at 3:30 p.m. ET.
Investors can access the webcast through the conference homepage or directly via the company-specific link, with replay options available afterward.
SenesTech (NASDAQ: SNES), the manufacturer of EPA-registered rodent birth control products, reported strong Q2 2025 financial results. The company achieved record revenue of $625,000, up 36% year-over-year, with Evolve™ Rodent Birth Control products growing 94% and representing 83% of total revenue.
Key highlights include record gross profit margin of 65.4%, improved from 54.2% in Q2 2024, and a net loss of $1.6 million. The company maintains a strong cash position of $11.2 million as of August 5, 2025, providing runway through 2027. SenesTech expanded its municipal pilot deployments across major U.S. cities and completed a move to a new automated manufacturing facility in July 2025.